I am writing in response to the article, “NIH Funds Program Aimed at Anesthesiology Drug Diversion” (Anesthesiology News 2020;46[2]:4), that quotes Tom Knight, the CEO of Invistics Corp., about software that helps detect drug diversion, an issue that the American Society of Anesthesiologists (ASA) takes very seriously.
Mary Dale Peterson, MD, MSHCA, FACHE, FASA
Physician anesthesiologists (as well